Back to Results

An Open-label, Phase 1b/2 Study of Acalabrutinib Alone or in Combination Therapy in Subjects with B-cell Non-Hodgkin Lymphoma

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Memorial Hospital Central
Memorial Hospital North
Pikes Peak Regional Hospital

Principal Investigator
Vishal Rana

Vishal Rana

Study ID

Protocol Number: 18-6510

More information available at ClinicalTrials.gov: NCT02180711

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers